SAGE Therapeutics IncNASDAQ:SAGE
- LAST PRICE7.5000
- TODAY'S CHANGE (%)-0.4000 (-5.0633%)
- Bid / Lots7.1600/ 1
- Ask / Lots8.0000/ 1
- Open / Previous Close8.0000 / 7.9000
- Day Range
- 52 Week Range
- Volume1,163,322
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAGE |
|---|---|---|
| 09:32 ET | 114446 | 7.84 |
| 09:34 ET | 856 | 7.85 |
| 09:36 ET | 300 | 7.86 |
| 09:38 ET | 100 | 7.78 |
| 09:39 ET | 100 | 7.83 |
| 09:45 ET | 400 | 7.79 |
| 09:50 ET | 800 | 7.76 |
| 09:52 ET | 200 | 7.77 |
| 09:54 ET | 200 | 7.78 |
| 09:56 ET | 400 | 7.73 |
| 09:57 ET | 807 | 7.7228 |
| 10:01 ET | 200 | 7.77 |
| 10:03 ET | 600 | 7.72 |
| 10:06 ET | 6404 | 7.68 |
| 10:08 ET | 100 | 7.67 |
| 10:10 ET | 700 | 7.685 |
| 10:12 ET | 100 | 7.68 |
| 10:14 ET | 200 | 7.67 |
| 10:15 ET | 200 | 7.67 |
| 10:17 ET | 300 | 7.67 |
| 10:19 ET | 1100 | 7.6446 |
| 10:21 ET | 600 | 7.65 |
| 10:26 ET | 1341 | 7.63 |
| 10:28 ET | 900 | 7.63 |
| 10:30 ET | 100 | 7.62 |
| 10:32 ET | 584 | 7.619 |
| 10:33 ET | 1683 | 7.6 |
| 10:35 ET | 100 | 7.6 |
| 10:37 ET | 400 | 7.59 |
| 10:39 ET | 200 | 7.58 |
| 10:42 ET | 2189 | 7.56 |
| 10:44 ET | 669 | 7.53 |
| 10:53 ET | 466 | 7.56 |
| 10:55 ET | 300 | 7.56 |
| 10:57 ET | 500 | 7.59 |
| 11:02 ET | 2438 | 7.579 |
| 11:04 ET | 4434 | 7.56 |
| 11:06 ET | 200 | 7.56 |
| 11:08 ET | 100 | 7.56 |
| 11:09 ET | 1400 | 7.54 |
| 11:11 ET | 500 | 7.53 |
| 11:13 ET | 508 | 7.55 |
| 11:18 ET | 861 | 7.54 |
| 11:20 ET | 344 | 7.55 |
| 11:22 ET | 200 | 7.56 |
| 11:24 ET | 300 | 7.54 |
| 11:27 ET | 200 | 7.5202 |
| 11:31 ET | 300 | 7.515 |
| 11:33 ET | 800 | 7.5 |
| 11:36 ET | 500 | 7.5001 |
| 11:38 ET | 434 | 7.52 |
| 11:40 ET | 100 | 7.55 |
| 11:47 ET | 100 | 7.57 |
| 11:51 ET | 200 | 7.55 |
| 11:58 ET | 391 | 7.57 |
| 12:00 ET | 3703 | 7.5899 |
| 12:02 ET | 400 | 7.56 |
| 12:05 ET | 100 | 7.57 |
| 12:07 ET | 113 | 7.565 |
| 12:14 ET | 200 | 7.56 |
| 12:20 ET | 218 | 7.56 |
| 12:21 ET | 100 | 7.56 |
| 12:30 ET | 240 | 7.55 |
| 12:36 ET | 100 | 7.54 |
| 12:38 ET | 100 | 7.53 |
| 12:39 ET | 274 | 7.525 |
| 12:41 ET | 150 | 7.535 |
| 12:48 ET | 900 | 7.53 |
| 12:50 ET | 106 | 7.53 |
| 12:52 ET | 1399 | 7.55 |
| 12:57 ET | 778 | 7.55 |
| 12:59 ET | 300 | 7.55 |
| 01:01 ET | 100 | 7.56 |
| 01:03 ET | 307 | 7.54 |
| 01:06 ET | 400 | 7.53 |
| 01:10 ET | 1102 | 7.54 |
| 01:12 ET | 350 | 7.55 |
| 01:14 ET | 988 | 7.56 |
| 01:15 ET | 400 | 7.56 |
| 01:17 ET | 200 | 7.57 |
| 01:19 ET | 400 | 7.56 |
| 01:21 ET | 700 | 7.57 |
| 01:24 ET | 1500 | 7.57 |
| 01:26 ET | 1547 | 7.54 |
| 01:28 ET | 1039 | 7.54 |
| 01:30 ET | 1461 | 7.52 |
| 01:32 ET | 200 | 7.52 |
| 01:33 ET | 300 | 7.53 |
| 01:35 ET | 760 | 7.53 |
| 01:37 ET | 300 | 7.53 |
| 01:39 ET | 100 | 7.53 |
| 01:42 ET | 400 | 7.54 |
| 01:44 ET | 700 | 7.55 |
| 01:46 ET | 100 | 7.54 |
| 01:48 ET | 500 | 7.53 |
| 01:50 ET | 213 | 7.52 |
| 01:51 ET | 300 | 7.52 |
| 01:53 ET | 276 | 7.53 |
| 01:55 ET | 1409 | 7.51 |
| 01:57 ET | 400 | 7.515 |
| 02:00 ET | 400 | 7.5 |
| 02:02 ET | 800 | 7.52 |
| 02:04 ET | 700 | 7.52 |
| 02:06 ET | 500 | 7.51 |
| 02:08 ET | 1300 | 7.54 |
| 02:09 ET | 400 | 7.53 |
| 02:11 ET | 1261 | 7.54 |
| 02:13 ET | 807 | 7.55 |
| 02:15 ET | 200 | 7.54 |
| 02:18 ET | 200 | 7.54 |
| 02:20 ET | 1400 | 7.55 |
| 02:22 ET | 2352 | 7.5501 |
| 02:24 ET | 200 | 7.55 |
| 02:26 ET | 200 | 7.55 |
| 02:27 ET | 387 | 7.56 |
| 02:29 ET | 400 | 7.55 |
| 02:31 ET | 300 | 7.52 |
| 02:33 ET | 303 | 7.525 |
| 02:36 ET | 300 | 7.52 |
| 02:38 ET | 300 | 7.525 |
| 02:40 ET | 1047 | 7.53 |
| 02:42 ET | 1426 | 7.54 |
| 02:44 ET | 500 | 7.54 |
| 02:45 ET | 200 | 7.53 |
| 02:47 ET | 300 | 7.5385 |
| 02:49 ET | 2900 | 7.57 |
| 02:51 ET | 143 | 7.57 |
| 02:54 ET | 215 | 7.57 |
| 02:56 ET | 200 | 7.56 |
| 02:58 ET | 976 | 7.56 |
| 03:00 ET | 1000 | 7.54 |
| 03:02 ET | 908 | 7.525 |
| 03:03 ET | 800 | 7.52 |
| 03:05 ET | 300 | 7.53 |
| 03:07 ET | 11102 | 7.49 |
| 03:09 ET | 800 | 7.45 |
| 03:12 ET | 3885 | 7.5 |
| 03:14 ET | 1645 | 7.47 |
| 03:16 ET | 1159 | 7.49 |
| 03:18 ET | 2742 | 7.48 |
| 03:20 ET | 2987 | 7.5 |
| 03:21 ET | 213 | 7.5 |
| 03:23 ET | 1400 | 7.51 |
| 03:25 ET | 300 | 7.5 |
| 03:27 ET | 488 | 7.51 |
| 03:30 ET | 300 | 7.51 |
| 03:32 ET | 3710 | 7.53 |
| 03:34 ET | 2352 | 7.52 |
| 03:36 ET | 200 | 7.51 |
| 03:38 ET | 4338 | 7.54 |
| 03:39 ET | 3801 | 7.58 |
| 03:41 ET | 2513 | 7.57 |
| 03:43 ET | 1820 | 7.57 |
| 03:45 ET | 5408 | 7.56 |
| 03:48 ET | 3880 | 7.565 |
| 03:50 ET | 2184 | 7.54 |
| 03:52 ET | 2435 | 7.54 |
| 03:54 ET | 3657 | 7.545 |
| 03:56 ET | 5543 | 7.545 |
| 03:57 ET | 5913 | 7.52 |
| 03:59 ET | 725908 | 7.5 |
Today
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGE, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesSAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Case, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGE, from 8 hours ago by Dow Jones
8 hours ago by Dow JonesSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit, from 8 hours ago by Dow Jones
8 hours ago by Dow JonesInvestors who Lost Money on Sage Therapeutics, Inc. (SAGE) Should Contact Levi & Korsinsky About Pending Class Action - SAGE, from 10 hours ago by Dow Jones
10 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SAGE Therapeutics Inc | 482.3M | -1.0x | --- |
Grail Inc | 430.7M | -0.1x | --- |
Urogen Pharma Ltd | 583.3M | -4.1x | --- |
Y-mAbs Therapeutics Inc | 624.0M | -24.4x | --- |
Regenxbio Inc | 617.8M | -2.2x | --- |
Fate Therapeutics Inc | 455.5M | -2.3x | --- |
Company Information
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.
Contact Information
- Headquarters
- 215 1st StCAMBRIDGE, MA, United States 02142-1213
- Phone
- 617-299-8380
- Fax
- 617-299-8379
Executives
- Independent Chairman of the Board
- Geno Germano
- President, Chief Executive Officer, Director
- Barry Greene
- Chief Financial Officer, Treasurer
- Kimi Iguchi
- Senior Vice President, General Counsel, Corporate Secretary
- Anne Cook
- Chief Business Officer
- Christopher Benecchi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $482.3M |
|---|---|
Revenue (TTM) | $97.2M |
Shares Outstanding | 61.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $-7.41 |
Book Value | $13.32 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -496.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
